Nolan Sean P. sold TSHA

January 23, 2026 · Form 4 insider transaction

Nolan Sean P. sold 136,789 shares of Taysha Gene Therapies, Inc. at $4.75 per share, a transaction worth $649.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
136,789
Price
$4.75
Total value
$649.7K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 23, 2026
Filing dateJanuary 27, 2026
Shares owned after2,949,569
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

View the original Form 4 on SEC EDGAR